Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005834Source: DataRank Database

In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 42 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access42 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: goldTopics (43)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Veronique Beiss ORCID,Gregory W Ho,Jennifer Fields ORCID,Nicole F. Steinmetz ORCID,Steven Fiering ORCID

Live enrichment

PubMed:36460333 PMC:PMC9723958

National Cancer Institute

Grant: R01CA224605

National Cancer Institute

Grant: R01CA253615

National Cancer Institute

Grant: U01CA218292

NIAID NIH HHS

Grant: T32 AI007363

NCI NIH HHS

Grant: P30 CA023108

National Institutes of Health

Grant: 5U01CA218292-03

Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.

National Institutes of Health

Grant: 5R01CA253615-03

Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer

National Institutes of Health

Grant: 3P30CA023108-41S8

Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA224605-08

Dual-pronged nano-drug delivery using plant virus-like particles

goldLicense: cc-by-nc

publisherhttps://jitc.bmj.com/content/jitc/10/12/e005834.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2022-005834

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9723958

repositoryhttps://doaj.org/article/bf7820d5e7f54df499adc412fa20ea20

repositoryhttps://escholarship.org/uc/item/9w58x9th

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

Dendritic CellsCD8-Positive T-LymphocytesAnimalsDogsMiceComovirusDisease Models, AnimalAdjuvants, ImmunologicImmunotherapyVaccinationImmune Checkpoint Inhibitors

Keywords

ImmunomodulationImmunotherapyVaccination570Oncology and CarcinogenesisImmunologyComovirus610CD8-Positive T-LymphocytesVaccine RelatedMiceDogsAdjuvants, ImmunologicImmunologicAnimalsAdjuvantsImmune Checkpoint InhibitorsRC254-282CancerBiomedical and Clinical SciencesAnimalInflammatory and immune systemNeoplasms. Tumors. Oncology. Including cancer and carcinogensDendritic CellsOncolytic and Local ImmunotherapyDisease Models, Animal5.1 PharmaceuticalsDisease ModelsImmunizationDevelopment of treatments and therapeutic interventions

Sustainable Development Goals

SDG 3: 3. Good health